Search Within

Gary Schwartz

  1. "Gastrointestinal Oncology Service"
Formats
  1. Journal Article (55)
  2. Meeting Abstract (42)
  3. Book Section (1)
  4. Conference Paper (1)
Groups
  1. Department of Medicine (99)
  2. Gastrointestinal Oncology Service (99)
  3. Solid Tumor Oncology Division (99)
  4. Center for Pancreatic Cancer Research (88)
  5. Biostatistics Service (24)
  6. Epidemiology and Biostatistics (24)

More Groups

People
  1. David Kelsen (79)
  2. Eileen O'Reilly (36)
  3. Leonard Saltz (30)
  4. Manish Shah (26)
  5. David Ilson (23)
  6. Nancy Kemeny (17)

More People

Years
  1. 2013 (4)
  2. 2012 (4)
  3. 2011 (1)
  4. 2010 (2)
  5. 2009 (3)
  6. 2008 (4)

More Years

Publications
  1. Journal of Clinical Oncology (29)
  2. Clinical Cancer Research (12)
  3. Cancer (9)
  4. Annals of Oncology (6)
  5. Proceedings of the American Association for Cancer Research Annual Meeting (6)
  6. Annals of Surgical Oncology (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (29)
  2. American Association for Cancer Research (18)
  3. Springer (11)
  4. Oxford University Press (10)
  5. Wiley Blackwell (10)
  6. Elsevier Inc. (7)

More Publishers

Results (99)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Vemurafenib (VEM) in patients (pts) with BRAF-mutant melanoma and brain metastases (mets)
    Meeting Abstract

    Harding, J. J.; Catalanotti, F.; Yaqubie, A.; McDermott, G. C.; Kersellius, R.; Merghoub, T.; Carvajal, R. D.; D'Angelo, S. P.; Dickson, M. A.; Schwartz, G. K.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Immunologic responses to xenogeneic tyrosinase DNA vaccine administered by electroporation in patients with malignant melanoma
    Journal Article

    Yuan, J.; Ku, G. Y.; Adamow, M.; Mu, Z.; Tandon, S.; Hannaman, D.; Chapman, P.; Schwartz, G.; Carvajal, R.; Panageas, K. S.; more...
    Journal for ImmunoTherapy of Cancer (2013)

    Fulltext@MSK | Save
  • Clinical activity of ipilimumab for metastatic uveal melanoma: A retrospective review of the Dana-Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and University Hospital of Lausanne experience
    Journal Article

    Luke, J. J.; Callahan, M. K.; Postow, M. A.; Romano, E.; Ramaiya, N.; Bluth, M.; Giobbie-Hurder, A.; Lawrence, D. P.; Ibrahim, N.; Ott, P. A.; more...
    Cancer (2013)

    Fulltext@MSK | Save
  • Ipilimumab for patients with advanced mucosal melanoma
    Journal Article

    Postow, M. A.; Luke, J. J.; Bluth, M. J.; Ramaiya, N.; Panageas, K. S.; Lawrence, D. P.; Ibrahim, N.; Flaherty, K. T.; Sullivan, R. J.; Ott, P. A.; more...
    The Oncologist (2013)

    Fulltext@MSK | Save
  • Evaluation of the absolute lymphocyte count as a biomarker for melanoma patients treated with the commercially available dose of ipilimumab (3mg/kg)
    Meeting Abstract

    Postow, M. A.; Yuan, J.; Panageas, K.; Bogatch, K.; Callahan, M.; Cheng, M.; Schroeder, S. E. A.; Kendle, R. F.; Harding, J. J.; Dickson, M. A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A multicenter random assignment phase II study of irinotecan and flavopiridol versus irinotecan alone for patients with p53 wild-type gastric adenocarcinoma (NCI 8060)
    Meeting Abstract

    Janjigian, Y. Y.; Tang, L. H.; Shibata, S.; Kelsen, D. P.; Segal, M.; Cheng, C.; Schwartz, G. K.; Doyle, L. A.; Shah, M. A.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A nonrandomized, phase II study of sequential irinotecan and flavopiridol in patients with advanced hepatocellular carcinoma
    Journal Article

    Ang, C.; O'Reilly, E. M.; Carvajal, R. D.; Capanu, M.; Gonen, M.; Doyle, L.; Ghossein, R.; Schwartz, L.; Jacobs, G.; Ma, J.; more...
    Gastrointestinal Cancer Research (2012)

    Fulltext@MSK | Save
  • Infliximab (IFX) for ipilimumab (IPI)-induced colitis in melanoma patients (pts)
    Meeting Abstract

    Harding, J. J.; Callahan, M.; Postow, M.; Rocco, K.; D'Angelo, S.; Dickson, M.; Carvajal, R.; Schwartz, G. K.; Wolchok, J.; Chapman, P.
    Pigment Cell & Melanoma Research (2012)

    Fulltext@MSK | Save
  • A phase 2 trial of erlotinib in patients with previously treated squamous cell and adenocarcinoma of the esophagus
    Journal Article

    Ilson, D. H.; Kelsen, D.; Shah, M.; Schwartz, G.; Levine, D. A.; Boyd, J.; Capanu, M.; Miron, B.; Klimstra, D.
    Cancer (2011)

    Fulltext@MSK | Save
  • A multicenter random assignment phase II study of irinotecan and flavopiridol versus irinotecan alone for patients with p53 wild-type gastric adenocarcinoma (NCI 8060)
    Meeting Abstract

    Shah, M. A.; Smyth, E. C.; Shibata, S.; Yong, W.; Tang, L. H.; Janjigian, Y. Y.; Kelsen, D. P.; Schwartz, G. K.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save